PpProf. Peptide
← Back to Supplement Library

Vitamin C

Recovery & Tissue Repair

Last reviewed: May 27, 2026

Also Known As: Ascorbic acid, ascorbate, L-ascorbic acid, sodium ascorbate (buffered form); related variant page: vitamin C for skin (cosmetic and skin-aging applications)

Supplement Class: Essential water-soluble vitamin / enzyme cofactor (collagen hydroxylation, neurotransmitter synthesis) / antioxidant / immune cell support / non-heme iron absorption enhancer

Evidence Tier: Multi-tier breakdown. Deficiency prevention: Strong (foundational essential vitamin; RDA-based intake prevents scurvy). Cold duration in regular supplementation: Moderate (Hemilä 2013 Cochrane — ~8% adult, ~14% child duration reduction at 200+ mg/day). General-population cold prevention: Negative. Extreme physical stress cold prevention: Moderate (~50% reduction in marathon runners, soldiers, arctic personnel). Iron absorption enhancement: Strong (Lynch 1980 — 2–3x non-heme iron uptake with 100 mg). High-dose IV (oncology, sepsis): Mixed, specialized. Cardiovascular hard outcomes: Weak. Cosmetic / skin-aging applications detailed separately on the vitamin-c-skin variant.

What is vitamin C?

Vitamin C (ascorbic acid) is an essential water-soluble vitamin that humans — unlike most other mammals — cannot synthesize endogenously due to a non-functional GULO gene. Dietary or supplemental intake is therefore required to prevent deficiency (scurvy). Vitamin C's biological roles are multi-layered: it's the irreplaceable cofactor for prolyl and lysyl hydroxylases (collagen hydroxylation — the mechanism behind scurvy when deficient), a primary water-soluble antioxidant donating electrons to neutralize reactive oxygen species, an immune cell support molecule that accumulates in lymphocytes at 50–100x plasma concentration, and the most important enhancer of non-heme iron absorption (converting ferric to ferrous iron in the gut). This page covers the foundational essential-vitamin role — deficiency prevention, cold support (Hemilä 2013 Cochrane), iron absorption, antioxidant defense, and the specialized high-dose IV protocols. Cosmetic and skin-aging applications — topical vitamin C serums, photoaging reversal, the Shaw 2017 collagen synthesis trial in detail, hyperpigmentation, and skin-stack pairings — are covered separately on the vitamin C for skin variant page. The honest framing for the foundational essential-vitamin role: RDA-level intake (75–90 mg/day non-smokers, 110–125 mg/day smokers) prevents scurvy. Regular 200–1000 mg/day modestly reduces cold duration (Hemilä Cochrane: ~8% adults, ~14% children) but does NOT prevent colds in the general population — except in extreme physical stress subpopulations (marathon runners, soldiers, arctic personnel) where ~50% incidence reductions are documented. 100 mg taken with iron-containing meals dramatically improves non-heme iron absorption (Lynch 1980 — 2–3 fold). Padayatty 2004 documents that oral plasma concentrations are tightly capped (~250 micromolar) due to saturable intestinal absorption and renal excretion — IV vitamin C bypasses these limits and reaches millimolar concentrations, where vitamin C has pro-oxidant effects relevant to specialized oncology and sepsis research. Practical implication: oral and IV vitamin C are pharmacokinetically distinct interventions; don't expect oral supplementation to substitute for IV protocols. Mega-doses (1000+ mg) around training may blunt mitochondrial biogenesis adaptations in competitive athletes (Paulsen 2014); modest supplementation outside training windows doesn't produce this effect.

Reported benefits:

  • Deficiency / scurvy prevention (foundational essential vitamin)
  • Modest cold duration reduction in regular supplementation (Hemilä 2013 Cochrane)
  • Substantial cold prevention in extreme physical stress (marathon, military, arctic populations)
  • 2–3 fold non-heme iron absorption enhancement (Lynch 1980)
  • Antioxidant defense and vitamin E regeneration
  • Immune cell support (lymphocyte accumulation, neutrophil function)
  • Collagen synthesis cofactor (Shaw 2017 — detailed cosmetic context on variant page)
  • Specialized high-dose IV protocols (oncology adjunct, sepsis — under medical supervision)

Common dose: 200–500 mg/day for general health; 75–125 mg/day for RDA; 200–1000 mg/day for cold-duration support; 100–250 mg with iron-containing meals for absorption enhancement. Absorption plateaus around 200 mg single doses — split larger daily totals. Tolerable upper limit 2000 mg/day from supplements.

Watch for: GI upset at high doses (loose stools at 2+ g single dose); kidney stone risk in oxalate-stone-prone users at 3+ g/day; hemochromatosis contraindication (iron-absorption enhancement is harmful in iron overload); chemotherapy regimen coordination; training adaptation blunting at mega-doses around exercise (Paulsen 2014); lab test interference at very high doses.

Shop Vitamin C on Amazon →

How does vitamin C work?

Vitamin C is an essential water-soluble vitamin with four core biological mechanisms relevant to supplementation: enzyme cofactor (most notably for collagen hydroxylation), water-soluble antioxidant (donating electrons to neutralize reactive oxygen species), immune cell support (accumulates in lymphocytes at 50–100x plasma concentration), and iron absorption enhancement (reducing ferric to ferrous iron in the gut).

  1. Essential enzyme cofactor (most notably for collagen hydroxylation). Vitamin C is an irreplaceable cofactor for prolyl and lysyl hydroxylases — enzymes that hydroxylate proline and lysine residues in nascent collagen chains. Hydroxylation is required for stable triple-helix collagen formation. Without adequate vitamin C, collagen is structurally weak — the mechanism behind scurvy. Vitamin C is also a cofactor for several other hydroxylases including those in carnitine biosynthesis and certain neurotransmitter synthesis steps.
  2. Water-soluble antioxidant. Vitamin C donates electrons to neutralize reactive oxygen species in the aqueous compartment of cells — complementary to vitamin E (lipid-soluble antioxidant in membranes). Vitamin C also regenerates oxidized vitamin E back to its active form, creating an antioxidant network. The antioxidant role is general and continuous — every cell uses some vitamin C for redox balance.
  3. Immune cell accumulation. Vitamin C accumulates in immune cells (lymphocytes, neutrophils) at concentrations 50–100x higher than plasma. It supports neutrophil chemotaxis, phagocytosis, and oxidative burst function. During infection, vitamin C is rapidly depleted from leukocytes — the basis of the immune-support indication.
  4. Iron absorption enhancement (non-heme iron specifically). Vitamin C reduces ferric (Fe³⁺) iron to ferrous (Fe²⁺) — the form transported by intestinal divalent metal transporter 1 (DMT1). Taking 100 mg vitamin C with an iron-containing meal produces 2–3 fold increases in non-heme iron absorption (Lynch 1980). Heme iron uses a separate transport pathway and is not enhanced by vitamin C.
  5. Saturable absorption / renal threshold. Oral vitamin C absorption plateaus around 200 mg single doses due to saturable intestinal transporters. Plasma concentrations are tightly capped (~250 micromolar) by renal excretion. This is why mega-doses produce diminishing returns — and why intravenous vitamin C produces pharmacologically distinct effects (Padayatty 2004 documents the IV vs oral pharmacokinetic difference).
  6. Pro-oxidant effects at very high plasma concentrations. At IV-achievable concentrations (millimolar), vitamin C has pro-oxidant rather than antioxidant effects — generating hydrogen peroxide that affects cancer cells more than normal cells. Basis of the IV vitamin C clinical research in oncology and sepsis. Cannot be reached via oral supplementation.
  7. Neurotransmitter synthesis. Vitamin C is required for dopamine beta-hydroxylase (dopamine → norepinephrine conversion) and aromatic amino acid hydroxylases involved in catecholamine synthesis. Mechanistically supports CNS catecholamine status; clinical translation is modest.

What does vitamin C actually do?

Vitamin C has one of the longest and most replicated evidence bases in nutrition. The honest summary varies by application: strong for preventing deficiency/scurvy, moderate for cold duration reduction (Hemilä Cochrane), moderate-to-strong for iron absorption enhancement, weak for general cold prevention in non-stressed populations, and specialized/mixed for high-dose IV protocols.

  1. Deficiency prevention (Strong, foundational). Vitamin C is an essential vitamin — humans cannot synthesize it, so dietary or supplemental intake is required to prevent scurvy. RDA: 75–90 mg/day non-smokers, 110–125 mg/day smokers. This is the foundational role.
  2. Cold duration reduction in regular supplementation (Moderate). Hemilä 2013 Cochrane: regular vitamin C supplementation (200+ mg/day) reduced cold duration by ~8% in adults and ~14% in children across pooled trials. Modest but consistent.
  3. Cold prevention in extreme physical stress (Moderate). Hemilä 2013: ~50% reduction in cold incidence in subpopulations under extreme physical stress (marathon runners, soldiers, arctic expedition personnel). Specific use case, not general-population prevention.
  4. General-population cold prevention (Negative). Same review: regular vitamin C did NOT reduce cold incidence in the general adult population. Vitamin C doesn't reduce how often you catch colds in typical settings.
  5. Iron absorption enhancement (Strong). Lynch 1980 and subsequent work documents 2–3 fold increases in non-heme iron absorption with 100 mg vitamin C at meals. Practical-protocol relevance for vegetarians, menstruating women, and iron-deficient populations.
  6. Antioxidant biomarker improvements (Moderate). Documented reductions in oxidative stress markers (lipid peroxidation products, oxidized LDL) with supplementation. Clinical-outcome translation is more variable.
  7. Cardiovascular protection (Modest). Observational associations between dietary vitamin C intake and reduced cardiovascular risk; modest BP reductions in some trials; improved endothelial function in oxidatively-stressed populations. Hard outcome RCTs (e.g., Physicians' Health Study) have not consistently demonstrated CV event reductions.
  8. Exercise recovery and reduced muscle soreness (Modest). Some trials document reduced markers of oxidative stress and faster recovery; effect varies with dose and exercise type.
  9. High-dose IV vitamin C in oncology (Mixed, specialized). Padayatty's NIH work documents IV vitamin C reaches pharmacologically distinct concentrations; clinical trials in cancer show mixed results — some QoL improvements adjacent to chemo, no consistent tumor response. Specialty integrative oncology use; not mainstream practice.
  10. Sepsis adjunct (Mixed). CITRIS-ALI and follow-up trials of IV vitamin C + thiamine + hydrocortisone in sepsis have shown mixed results. Some early-sepsis signal but not consistent enough for guideline adoption.
  11. Collagen synthesis (Strong, mechanistic). Vitamin C is the irreplaceable cofactor for collagen hydroxylation — this is fundamental biochemistry. Shaw 2017 demonstrated trial-level effects on collagen synthesis markers. Cosmetic/skin-aging applications covered in detail on the vitamin-c-skin variant page (see Related Supplements).
  12. Training adaptation blunting at very high doses (Note). Paulsen 2014 and similar trials suggest mega-dose antioxidant supplementation around training may blunt mitochondrial biogenesis and exercise-induced angiogenesis adaptations. Modest supplementation outside training windows doesn't appear to do this.

How is vitamin C dosed?

Vitamin C dosing depends on goal. For preventing deficiency (the foundational role): 75–125 mg/day matches RDA. For cold duration / general antioxidant support: 200–500 mg/day. For exercise recovery: 500–1000 mg/day. For specific clinical contexts (sepsis, oncology adjunct): much higher doses under medical supervision. Absorption plateaus around 200 mg single doses — splitting larger daily totals is more efficient than single mega-doses.

  1. Deficiency prevention (RDA). 75–90 mg/day for non-smokers, 110–125 mg/day for smokers. Easily met by fruit and vegetable intake; supplementation provides insurance.
  2. General health / antioxidant support. 200–500 mg/day. Most common supplemental dose range.
  3. Cold duration support (chronic). 200–1000 mg/day regular supplementation per Hemilä Cochrane evidence. Higher end (1000 mg) for users under high physical stress.
  4. Acute cold symptoms protocol. 1000 mg every few hours for 24–48 hours at first symptoms (total 3–4 g/day), then taper. GI tolerance limits dose; split servings; back off if loose stools.
  5. Iron absorption enhancement. 100–250 mg taken with iron-containing meals or iron supplements. Doesn't need to be daily — only with iron intake.
  6. Exercise recovery. 500–1000 mg/day, ideally after rather than before training to avoid potential adaptation blunting. Modest doses (200–500 mg) outside training are safe.
  7. High-dose / IV protocols. Specialized clinical contexts (oncology adjunct, sepsis, certain inflammatory conditions) — medical supervision only.

Timeline: deficiency prevention is continuous; cold-duration effects emerge from chronic supplementation; iron absorption effect is acute (with each meal). Cardiovascular and inflammatory marker effects emerge over weeks.

Form note. Ascorbic acid is the standard form and what most clinical evidence uses. Sodium ascorbate (buffered form) is gentler on stomach for users prone to GI upset. Liposomal vitamin C produces higher plasma levels at high doses but adds cost and isn't necessary at typical supplemental doses. Ester-C (calcium ascorbate + metabolites) — marketing claims of better absorption are not well-supported in trials.

How to take vitamin C

Vitamin C is taken orally as tablets, capsules, powder (best for high doses), or chewable forms. The practical considerations are dose splitting (absorption plateau at 200 mg single doses), pairing with iron-containing meals for absorption enhancement, and avoiding immediate-around-training mega-doses for serious athletes.

AspectRecommendation
Frequency1–3× daily depending on dose. For 200–500 mg: 1× daily is fine. For 1000+ mg: split into 2–3 servings (absorption plateaus around 200 mg single dose). For acute illness protocols: every few hours.
Best time of dayAny time. Morning with breakfast pairs with iron-containing breakfasts. For exercise recovery: post-workout rather than pre-workout. For serious athletes targeting adaptation: outside training window.
FoodWith or without food per tolerance. WITH iron-containing meals (or iron supplements) for the absorption-enhancement effect. Avoid taking with calcium supplements or coffee/tea — those reduce iron absorption.
FormAscorbic acid is the standard. Sodium ascorbate (buffered) for users with sensitive stomach. Liposomal at high doses if absorption is the limiting factor. Powder for cost-efficient high-dose use. Avoid "Ester-C" marketing claims — not well-supported.
Standardization markerPharmaceutical-grade ascorbic acid from cGMP-certified facility. Third-party tested. Reputable brands: Now Foods, Thorne, Pure Encapsulations, Doctor's Best, Solgar, Life Extension, NutraBio.
Cycling / storageNo cycling required — chronic daily use is the trial-validated norm. Store in cool dry conditions; vitamin C is degraded by heat, light, and moisture over time. Use opened bottles within 12 months.

What does vitamin C stack with?

Vitamin C pairs naturally with iron (absorption enhancement), the broader antioxidant family (vitamin E, glutathione precursors), collagen-supporting compounds, and immune-supporting stacks. The three areas below cover the natural stacking categories.

With peptides

Vitamin C's collagen-cofactor role means it pairs naturally with tissue-healing peptides via the connective-tissue substrate pathway. BPC-157 and TB-500 drive tissue repair signaling; collagen synthesis requires vitamin C; vitamin C ensures the substrate-cofactor side of the equation isn't the limiting factor. GHK-Cu (tripeptide-copper complex) for skin and dermal extracellular matrix has vitamin C as a complementary cofactor. None of these combinations have formal RCT validation but the mechanistic rationale is direct.

With supplements

  1. Iron supplements — take 100–250 mg vitamin C with iron for the 2–3 fold absorption enhancement (Lynch 1980). Particularly relevant for iron deficiency anemia treatment.
  2. Collagen peptides — vitamin C is the irreplaceable cofactor for collagen hydroxylation; supplementing collagen substrate without adequate vitamin C limits collagen synthesis. Foundational pairing for skin, joint, and connective tissue protocols.
  3. Hyaluronic acid — completes the foundational skin-stack (collagen + HA + vitamin C).
  4. Vitamin E — complementary antioxidant; vitamin C regenerates oxidized vitamin E. Modest stacking benefit.
  5. Zinc — common immune-support pairing. Cold-duration protocols often combine vitamin C + zinc lozenges.
  6. Glutathione precursors (NAC, glycine, glutamine) — broader antioxidant network support.
  7. Quercetin — flavonoid with overlapping antioxidant and immune mechanism; common stacking partner.
  8. Vitamin D3 — foundational immune support; compatible co-supplementation.
  9. Bioflavonoids (rose hips, citrus bioflavonoids) — sometimes combined with vitamin C in commercial products; modest mechanistic basis.
  10. L-arginine and glutamine — surgical immunonutrition co-supplements. Wound healing context.

With lifestyle

  1. Dietary vitamin C from fruits and vegetables. Citrus, bell peppers, kiwi, strawberries, broccoli. Supplementation is additive to dietary intake, not a substitute.
  2. Pair with iron-rich plant meals. Beans, lentils, spinach, fortified grains — vitamin C with these meals dramatically improves iron uptake.
  3. Avoid coffee/tea with iron-containing meals. Tannins reduce iron absorption; vitamin C cannot fully overcome the effect.
  4. Smoking increases vitamin C requirements. Smokers have ~35% higher RDA. Smoking also dramatically increases oxidative stress.
  5. High training volumes increase requirements. Athletes often benefit from higher intake than RDA, particularly during intense training blocks or competition periods.
  6. Sun damage and oxidative stress contexts. UV exposure depletes skin vitamin C — topical vitamin C serums address this directly (see vitamin-c-skin variant).
  7. Stress and illness recovery. Vitamin C is rapidly depleted during active infection and severe stress.

Side effects and interactions

Vitamin C has an exceptional safety profile. Water-soluble; excess excreted in urine; no documented toxicity at typical supplemental doses. The main practical considerations are GI upset at high doses, kidney stone risk in predisposed users at very high doses, and modest interaction with chemotherapy regimens.

Common (mostly transient)

  1. GI upset (loose stools, diarrhea, nausea) at high doses — typically above 2 g/day single dose or 4 g/day total. The tolerable upper limit from supplements is 2000 mg/day.
  2. Mild stomach acidity with ascorbic acid form — sodium ascorbate (buffered) resolves this in sensitive users.
  3. No documented serious adverse events at standard supplemental doses in healthy adults.

Less common (watch-list)

  1. Kidney stone risk in predisposed users. Very high doses (3+ g/day) may increase oxalate stone formation in users with history of calcium oxalate kidney stones. Coordinate with nephrology if stone history.
  2. Hemochromatosis (iron overload). Vitamin C's iron-absorption enhancement is harmful in users with hereditary hemochromatosis. Avoid or coordinate with hematology.
  3. G6PD deficiency. Very high doses can theoretically trigger hemolysis in G6PD-deficient users. Modest doses are fine.
  4. Lab test interference. Very high doses (1+ g/day) can interfere with some lab tests (fecal occult blood, urine glucose, certain blood glucose meters). Inform lab if testing during high-dose protocols.
  5. Training adaptation blunting at mega-doses around exercise. Paulsen 2014 finding for serious athletes. Modest supplementation doesn't do this.

Drug and supplement interactions

  1. Chemotherapy regimens. Some chemo agents (bortezomib, methotrexate) have theoretical interactions with high-dose vitamin C — coordinate with oncology. Routine supplementation at typical doses is generally compatible.
  2. Iron supplements and iron-containing meals. Beneficial interaction — vitamin C dramatically enhances non-heme iron absorption.
  3. Aluminum-containing antacids. Vitamin C may increase aluminum absorption — relevant in renal disease.
  4. Warfarin. Theoretical interaction at very high doses; generally well-tolerated at standard supplementation. Monitor INR if starting high-dose vitamin C while on warfarin.
  5. Estrogen and oral contraceptives — modest effect on estrogen metabolism at very high doses. Clinical significance unclear.
  6. Pregnancy and breastfeeding — generally safe at standard supplemental doses. Coordinate with obstetrician for very high doses.

What we don't know yet about vitamin C

Vitamin C is one of the longest-studied supplements but several questions remain — particularly around optimal dose, individual variability, and where the boundaries are between beneficial and counterproductive doses.

Optimal supplemental dose for outcomes beyond deficiency prevention. RDA prevents scurvy. Optimal dose for cardiovascular protection, cancer prevention, cognitive aging, and other long-term outcomes is debated. Trials at 200–1000 mg/day are the practical standard but the dose-response above RDA isn't precisely characterized.

Individual responder variability. Why some users see meaningful cold-duration effects and others don't isn't fully characterized. Possibly related to baseline vitamin C status, gut microbiome, genetic polymorphisms in vitamin C transporters (SVCT1, SVCT2).

Training adaptation blunting dose-response. Paulsen 2014 and similar trials suggest very high antioxidant supplementation may blunt training adaptations. Precise threshold above which this happens — and whether the effect applies across all training modalities — isn't precisely characterized.

IV vitamin C clinical role. Pharmacokinetic distinction from oral is clear (Padayatty 2004); clinical-outcome translation in oncology and sepsis remains mixed. Specific patient subgroups and integration timing may matter more than has been characterized in current trials.

Liposomal vs standard oral at therapeutic doses. Higher plasma levels with liposomal at high doses are documented; whether the higher plasma levels translate to better clinical outcomes for specific applications isn't precisely characterized in head-to-head trials.

Cancer prevention vs cancer adjunct. Cancer prevention RCTs (Physicians' Health Study and similar) have been largely null. Cancer adjunct evidence for IV vitamin C is mixed. The biology suggests some role exists but operationalizing it isn't fully resolved.

Aging and vitamin C status. Some research suggests older adults have lower baseline plasma vitamin C despite adequate intake — possibly related to absorption decline. Whether higher supplemental doses are warranted in older adults isn't precisely characterized.

Synergy with other nutrients. Vitamin C's role in vitamin E recycling, the broader antioxidant network, and collagen synthesis cofactor function suggests synergistic effects with co-nutrient supplementation. Magnitude and clinical translation isn't precisely characterized for most pairings.

Where to buy vitamin C

Vitamin C is one of the most commoditized supplements — quality is uniform across reputable brands, and cost is dominated by form (tablets vs liposomal vs Ester-C marketing). Pharmaceutical-grade ascorbic acid is the standard form with the strongest evidence base.

Quality markers to look for

  • Pharmaceutical-grade ascorbic acid — the form used in most clinical trials. Standard and most cost-efficient choice for general supplementation.
  • Sodium ascorbate (buffered) for users with sensitive stomach. Same biological effect, gentler on GI.
  • Liposomal vitamin C for high-dose therapeutic use only — produces higher plasma levels at high doses but adds significant cost. Not necessary at typical supplemental doses.
  • Avoid Ester-C marketing claims — "ester" absorption claims are not well-supported by independent research vs standard ascorbic acid.
  • cGMP-certified manufacturing facility — minimum bar.
  • USP / NSF / ConsumerLab certified — third-party verification of label claims and purity.
  • Powder for high-dose users — much more cost-efficient than capsules at 1+ g/day. Mixes in water or juice.
  • Reputable brands — Now Foods, Thorne, Pure Encapsulations, Doctor's Best, Solgar, Life Extension, NutraBio. Generic brand variation in this category is minimal — quality is dominated by manufacturing certification rather than brand name.
  • Avoid "immune blend" sub-therapeutic products — many multivitamins and immune blends include token vitamin C in trace amounts. Buy single-ingredient and combine deliberately.
  • Topical vitamin C serums are a separate product category for skin applications — see the vitamin-c-skin variant for cosmetic/anti-aging context.
Shop Vitamin C on Amazon →

Amazon affiliate link — Prof. Peptide earns a small commission on qualifying purchases at no extra cost to you. We use commissions to fund research and editorial work.

Vitamin C FAQ

How much vitamin C should I take?

Depends on goal. For preventing deficiency (RDA): 75–90 mg/day for non-smokers, 110–125 mg/day for smokers. For general health and antioxidant support: 200–500 mg/day. For cold duration/prevention (Hemilä Cochrane evidence): regular 200–1000 mg/day reduces cold duration ~8% in adults; supplementing at first symptoms may have additional effect. For exercise recovery: 500–1000 mg/day. For specific clinical contexts (sepsis, cardiac surgery, cancer adjunct): much higher doses under medical supervision. The tolerable upper limit is 2000 mg/day from supplements — doses above this commonly cause GI upset. Higher doses are not better for most users; absorption plateaus around 200 mg single doses.

Does vitamin C actually prevent colds?

Honest answer: not really for prevention in most healthy adults, but it does shorten duration modestly. The Hemilä Cochrane review (the most-cited single source) found regular vitamin C supplementation (200+ mg/day) reduced cold duration by approximately 8% in adults and 14% in children. Prevention effect in the general population was null — taking vitamin C daily doesn't reduce how often you catch colds. Two specific subpopulations did show prevention effects: people under extreme physical stress (marathon runners, soldiers, arctic expedition personnel) showed approximately 50% reduction in cold incidence with regular vitamin C. Starting vitamin C at first symptoms (rather than chronically) has mixed evidence — some trials show duration shortening, others show no effect. Practical framing: vitamin C is a worthwhile deficiency-prevention supplement; modest cold-duration benefit if you supplement regularly; not a panacea against colds. See the zinc lozenge protocol for more potent cold-duration evidence.

Should I take more vitamin C when I have a cold?

Probably worth trying, with realistic expectations. Once a cold has started, vitamin C's evidence is weaker than for chronic prevention. Some studies show modest symptom-severity reductions at therapeutic doses (1000+ mg/day) started at first symptoms; others show no effect. Mechanism is plausible — vitamin C is rapidly consumed by activated immune cells during infection, and supplementation may support cellular demands. Practical protocol if you want to try: 1000 mg every few hours during the first 24–48 hours of symptoms (total 3–4 g/day), then taper as symptoms resolve. GI tolerance is the limiting factor at this dose — split servings and back off if loose stools develop. For more potent cold-duration intervention, consider zinc acetate lozenges — Singh Cochrane found ~33% duration reduction when started within 24 hours of symptoms.

Is high-dose IV vitamin C a real treatment for cancer or sepsis?

Real research, mixed clinical evidence, specific contexts only. Intravenous vitamin C achieves plasma concentrations (millimolar range) that oral supplementation cannot reach (capped at ~250 micromolar) — and at IV concentrations, vitamin C has pro-oxidant effects on cancer cells. Padayatty's NIH work documents this pharmacokinetic difference. Clinical trials of IV vitamin C in cancer have shown mixed results — some quality-of-life improvements adjacent to chemotherapy, no consistent tumor response. Some integrative oncology practices use IV vitamin C; mainstream oncology does not. For sepsis: the CITRIS-ALI trial and follow-up RCTs showed mixed results — some signal in early sepsis but not consistent enough for guideline adoption. Practical framing: oral vitamin C cannot reach IV concentrations; these are specialized clinical-context interventions, not equivalent to oral supplementation. Don't expect oral vitamin C to substitute for cancer treatment.

Does vitamin C help me absorb iron?

Yes, significantly, for non-heme iron. Vitamin C converts non-heme iron (the iron form in plant foods and most iron supplements) from the ferric (Fe³⁺) form to the ferrous (Fe²⁺) form — dramatically increasing its intestinal absorption. Taking 100 mg of vitamin C alongside iron-rich plant foods or iron supplements can improve iron uptake 2–3 fold. This is particularly relevant for vegetarians, women with heavy menstrual periods, athletes prone to iron-deficiency anemia, and pregnant women. Heme iron (from meat) doesn't need vitamin C for absorption — it's absorbed through a separate transport pathway. Practical implication: if you're supplementing iron or eating mostly plant-based for iron, take 100–250 mg vitamin C with your iron-containing meal. Note: don't take with calcium (which inhibits iron absorption) or with high-tannin beverages (coffee, tea).

Can high-dose vitamin C blunt my training adaptations?

Possibly, at very high doses. Some research (Paulsen 2014 and similar trials) suggests that very high antioxidant supplementation (1000+ mg vitamin C + 400 IU vitamin E) blunts the oxidative stress signals that drive certain training adaptations — specifically mitochondrial biogenesis and exercise-induced angiogenesis. Effect appears specifically related to high-dose antioxidant supplementation timed around training, not modest supplementation. Practical implications: (1) For competitive athletes targeting maximum training adaptation, avoid mega-doses (1000+ mg) of vitamin C immediately around training sessions. (2) Modest supplementation (200–500 mg/day) taken away from training is unlikely to blunt adaptations. (3) Post-exercise recovery use (1000 mg post-workout) may be a reasonable compromise — the immediate window is more recovery-focused than adaptation-driving.

Is liposomal vitamin C actually better than regular vitamin C?

Modestly, at high doses; not meaningfully at typical supplemental doses. Standard oral vitamin C absorption plateaus around 200 mg single doses — additional vitamin C beyond this gets excreted. Liposomal vitamin C (vitamin C encapsulated in phospholipid spheres) bypasses the conventional absorption pathway and produces higher plasma levels at given oral doses. For doses up to 500 mg, the difference between standard and liposomal vitamin C in plasma levels is modest — saturable absorption isn't the rate-limiting step yet. At very high doses (3 g+ daily for clinical purposes), liposomal can produce meaningfully higher plasma levels. For typical health-and-immune supplementation (500 mg/day): standard vitamin C is cost-efficient and effective. Liposomal makes sense for specific therapeutic protocols at higher doses or for users with absorption issues.

Is this page about skin/cosmetic vitamin C effects?

No — this page covers vitamin C's foundational essential-vitamin role: deficiency prevention, immune function, antioxidant defense, iron absorption, and cold duration. Vitamin C's cosmetic and skin-aging applications — topical formulations, photoaging, wrinkle reduction, the Shaw 2017 collagen synthesis trial, vitamin C serums, and skin-stack details — are covered separately on the vitamin C for skin profile. The Shaw 2017 collagen finding (vitamin C-enriched gelatin increased collagen synthesis markers) is mentioned briefly here but the broader cosmetic/anti-aging discussion belongs in the skin-specific profile.

References

  1. Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013;(1):CD000980. https://pubmed.ncbi.nlm.nih.gov/23440782/
  2. Padayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140(7):533-537. https://pubmed.ncbi.nlm.nih.gov/15068981/
  3. Hemilä H. Vitamin C supplementation and common cold symptoms: problems with inaccurate reviews. Nutrition. 2017;33:357. https://pubmed.ncbi.nlm.nih.gov/27613532/
  4. Shaw G, Lee-Barthel A, Ross ML, Wang B, Baar K. Vitamin C-enriched gelatin supplementation before intermittent activity augments collagen synthesis. Am J Clin Nutr. 2017;105(1):136-143. https://pubmed.ncbi.nlm.nih.gov/27852613/
  5. Lynch SR, Cook JD. Interaction of vitamin C and iron. Ann N Y Acad Sci. 1980;355:32-44. https://pubmed.ncbi.nlm.nih.gov/6940487/
  6. Paulsen G, Cumming KT, Holden G, et al. Vitamin C and E supplementation hampers cellular adaptation to endurance training in humans: a double-blind, randomised, controlled trial. J Physiol. 2014;592(8):1887-1901. https://pubmed.ncbi.nlm.nih.gov/24492839/

Published Studies

Plain-English summaries of the peer-reviewed studies behind the claims above. Click any title to read the source paper.

Cochrane Database of Systematic Reviews · 2013Open Access
Vitamin C for Preventing and Treating the Common Cold →

Hemilä H, Chalker E

The foundational Cochrane systematic review of vitamin C for cold prevention and treatment. Pooled 29 trial comparisons (over 11,000 episodes). Regular vitamin C supplementation (200+ mg/day) did not prevent colds in the general adult population, but did reduce duration by approximately 8% in adults and 14% in children. In subpopulations under extreme physical stress (marathon runners, soldiers, arctic expedition personnel), regular vitamin C reduced cold incidence by approximately 50%. Therapeutic vitamin C started at symptom onset has mixed evidence. The most-cited single source for the "modest cold-duration effect; no general-population prevention" framing.

Annals of Internal Medicine · 2004Open Access
Vitamin C Pharmacokinetics: Implications for Oral and Intravenous Use →

Padayatty SJ, Sun H, Wang Y, et al.

The foundational pharmacokinetic study from NIH documenting that oral vitamin C plasma concentrations are tightly capped (~250 micromolar) by saturable intestinal absorption and renal excretion. Intravenous vitamin C bypasses these limits and reaches millimolar concentrations (10x higher) — at which vitamin C has pro-oxidant rather than antioxidant effects. Foundational reference for understanding why oral and IV vitamin C are not pharmacokinetically equivalent and why high-dose IV protocols exist as a specialized intervention class.

Nutrition · 2017Open Access
Vitamin C Supplementation and Common Cold Symptoms: Problems with Inaccurate Reviews →

Hemilä H

A follow-up review and meta-analysis examining vitamin C effects on cold symptom severity specifically. Documents modest symptom-severity reductions in regular supplementation cohorts. Useful supplement to the 2013 Cochrane review — addresses the dose-response and symptom-severity questions that the prevention/duration framing leaves underspecified.

American Journal of Clinical Nutrition · 2017Open Access
Vitamin C-Enriched Gelatin Supplementation Before Intermittent Activity Augments Collagen Synthesis →

Shaw G, Lee-Barthel A, Ross ML, Wang B, Baar K

An RCT demonstrating that vitamin C-enriched gelatin taken 1 hour before exercise significantly increased markers of collagen synthesis (PINP, a procollagen marker) compared to placebo. Mechanism: vitamin C is the irreplaceable cofactor for prolyl and lysyl hydroxylases — enzymes that hydroxylate collagen chains for stable triple-helix formation. Brief mention on this profile; detailed cosmetic/skin-aging context covered on the vitamin-c-skin variant page.

Annals of the New York Academy of Sciences · 1980Paywalled
Effect of Iron Absorption Enhancement with Ascorbic Acid →

Lynch SR, Cook JD

The foundational study quantifying vitamin C's effect on non-heme iron absorption. 100 mg vitamin C taken with an iron-containing meal produced 2–3 fold increases in non-heme iron absorption. Mechanism: vitamin C reduces ferric (Fe³⁺) to ferrous (Fe²⁺) iron, which is the form transported by intestinal divalent metal transporter 1 (DMT1). Heme iron uses a separate pathway and is not enhanced by vitamin C. Practical-protocol reference for iron-deficiency anemia adjunctive supplementation.

Essential VitaminCold DurationIron AbsorptionAntioxidantHemilä CochraneCollagen Cofactor

Related Supplements

Vitamin C for SkinZincVitamin D3Collagen PeptidesHyaluronic AcidQuercetin

We may earn commissions from peptide vendor affiliate links.

Have a question about Vitamin C? Send us an email →